• Print ISSN: 0976-948X
  • Online ISSN: 3048-5738
  • NAAS Rating: 3.35
Experimental Pathogenicity of Papiliotrema laurentii in Swiss Albino Mice
Volume 9 | Issue 2 | June 2023
AUTHOR(S)
Nurul Islam, Rupjyoti Bharali, Hridip Kumar Sarma, Sailen Talukdar, Shameem Ara Begum, Afzal Hoque Akand, Subhash Sarma, Syed Akram Hussain

ABSTRACT

Cryptococcus may be found as pathogenic fungi which have rarely been studied. In this study the virulence factor of non-neoformans Cryptococcus species, biological characteristics of the fungal pathogen and pathophysiology of mice infected with the Cryptococcal species Papiliotrema laurentii compared with normal mice for definite time intervals. All the test mice were inoculated with the yeast cells of cryptococcal organisms that showed an almost uniform pattern of behavior in relation to the isolation of the same specific organisms from different organs of the infected mice during the interval of the experimental period. Tissue samples were studied after processing from the both dead and also from the mice scarified on the scheduled day of post infection except from those of the control group. The yeast cells were cultured following standard protocol and the biological characteristics were also studied. The pathogenicity of non-neoformans species of the genus did not show much pathogenicity in mice. The findings of the present study also indicated that the cultural and biochemical characteristics and, also pathophysiology of the species Papiliotrema laurenti in mice. However, No recovery of Papiliotrema laurentii was observed from any organs on this specific day of post infection with this organism i.e. Papiliotrema laurentii which made the study a significant observation. The pathogenic effects of this species were not the same in different time intervals. This reflects that virulence factors are related to time intervals in mice infection regimens before isolation from organs. Histopathological findings also were found from liver and brain. As Cryptococcosis a zoonotic disease, study of virulence factors of the organisms in mice modal may help in understanding the transmission of this disease and its pathogenicity.

Averbuch D, Boekhout T, Falk R, Engelhard D, Shapiro M, Block C, Polacheck I. Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Medical Mycology, 2002, https://doi.org/10.1080/mmy.40.5.479.484.
Banerjee A, Pradhan S, Debnath C, Baidya S, Patra NC, Hansda RN, Mondal S, and Mukhopadhyay SK. In-Vitro and In-Vivo Pathogenicity Study of Cryptococcus Species. International Journal of Current Microbiology and Applied Sciences. 2017; 6 (12): 2495-503. doi:https://doi.org/10.20546/ijcmas.2017.612.290
Bernardo FM, Martins HM, Martins ML. Fontes urbanas de. Cryptococcus spp. – Lisboa Urban Sources of Cryptococcus spp – Lisbon (Portugal). Revista Portuguesa de Ciencias Veterinarias, 2001.
Buchanan KL, Murphy JW. What makes Cryptococcus neoformans a pathogen? Emerging Infectious Diseases. 1998; 4: 71.
Chakrabarti A, Singh K, and Jatana M. Medical Mycology Laboratory Procedures: International Workshop. on Medical Mycology. 1998. Department of Medical Microbiology, PGIMER, Chandigarh, India.
Chander J. Medical Mycology, 2nd Edition, New Delhi, India, Metha Publishers, 2002.
Cheng MF, Chiou CC, Liu YC, Wang HZ, Hsieh KS. Cryptococcus laurentii fungemia in a premature neonate. Journal ofClinical Microbiology. 2001; doi:10.1128/JCM.39.4.1608-1611.2001.
Christensen WB. Urea decomposition as a means of differentiating Proteus and Paracolon cultures from each other and from Salmonella and Shigella types’, Journal of Bacteriology. 1946; 52: 461-6.
Culling CFA. Handbook of histopathological and histochemical techniques. 3rd edition. Butter Worths and Co. (publishers), Ltd. London, 1963.
De Bernardis F, Palliola E, Lorenzini R, Antonucci G. Evaluation of the experimental pathogenicity of some Cryptococcus species in normal and cyclophosphamide-immunosuppressed mice. Microbiologyand Immunology. 1987; 31(5): 449–60.
Duke SS, Fromtling RA. Effect of diethylstilbestrol and cyclophosphamide on the pathogenesis of experimental Cryptococcus neoformans infections. Sabouraudia, 1984, 22: 125-35.
Fell JW, and Statzell-Tallman A. Cryptococcus Vuillemin. In: Kurtzman C P and Fell J W editors. The yeasts: a taxonomic study. Amsterdam: Elsevier. 1998; 742–67.
Graybil JR, and Mitchell L. Cyclophosphamide effects on murine cryptococcosis. Infection and Immunology. 1978; 21: 674-7.
Grosse G, Mishra SK, Staib F. Selective involvement of the brain in experimental murine Cryptococcosis. Zbl. Bakt. Hyg. I. Abt. Orig. A. 1975; 233: 106-22.
Gyu-Nam Park, Sun-Young Kim, Hye-Ran Kim, Bo-Kyung Jung, Dong-Jun An, Seung-Bok Hong, Kyung-Soo Chang. Comparison of Virulence between Five Strains of Cryptococcus Species Complex in a Rat Model. Biomedical Scientific Letters. 2018; 24(3): 183-95.
Hansong MN, Robin C M. Virulence in Cryptococcus species (AllenIL, Sima S, Geoffery MG. Eds.). Advances applied Microbiol. B.L.190. 2009. Academic Press, Burlington.
Huang YH, Lin IH, Chang TC, Tseng SH. Early diagnosis and successful treatment of Cryptococcus albidus keratitis. Medicine (United States). 2015. https://doi.org/10. 1097/MD.0000000000000885.
Islam N, Bharali R, Talukdar S, Hussain SA, Akand AH, Sarma HK.Journal of Pure and Applied Microbiology. 2020; 14(4).
Jang YH, Lee SJ, Lee JH, Chae HS, Kim SH, Choe NH. Prevalence of yeast-like fungi and evaluation of several virulence factors from feral pigeons in Seoul, Korea. Letters in AppliedMicrobiology. 2011; https://doi.org/10.1111/j.1472-765X.2011.03009.x
Kamari A, Sepahvand A, Mohammadi R. Isolation and molecular characterization of Cryptococcus species isolated from pigeon nests and Eucalyptus trees. Current Medical Mycology. 2017; https://doi.org/10.29252/cmm.3.2.20.
Known-Chung KJ, and Bennett JE. Medical Mycology, 1stEdn. Lea and Febiger, Philiadelphia, USA, 1992.
Liu Y, Ma S, Wang X, Xu W, Tang J. Cryptococcus albidus encephalitis in newly diagnosed HIV-patient and literature review. Medical Mycology Case Reports. 2014. https://doi.org/ 10.1016/j.mmcr.2013.11.002.
Luna LG. Manual of histologic staining methods of Armed Forces Institute of Pathology. 3rd Edn., McGrew-Hill, Toronto, Sydney. 1968.
McFaddin JF. Media for isolation, identification, maintenance of medical bacteria. Vol. 1. Baltimore, Md. William and Wilkins. 1995.
Negroni R. Cryptococcosis. Clinical Dermatology. 2012; 30: 599-609.
Nishimura K, Miyaji M. Histopathological studies on experimental cryptococcosis in nudemice. Mycopathologia. 1979; 68: 145-53.
Okubo Y, Wakayama M, Ohno H, Yamamoto S, Tochigi N, Tanabe K, Kaneko Y, Yamagoe S, Umeyama T, Shinozaki M, Nemoto T, Nakayama H, Sasai D, Ishiwatari T, Shimodaira K, Yamamoto Y, Kamei K, Miyazaki Y, Shibuya K. Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans. Japanese Journal of Infectious Diseases. 2013; 66: 216-21.
Pal M. Use of Pal’s sunflower seed medium for an early diagnosis of cryptococcosis. Antiseptic, 1997; 94: 175.
Pal M,and Dave P. Cryptococcosis: A global fungal zoonosis. Intas Polivet. 2006; 6: 412-20.
Pedroso RS, Ferreira JC, Candido RC. The isolation and characterization of virulence Factors of Cryptococcus spp. from saprophytic sources in the city of Ribeira˜o Preto, Sa˜o Paulo, Brazil. Microbiological Research. 2009a; 164: 221–7. doi: 10.1016/j.micres.2007.01.002.
Pedroso RS, FerreiraJC, Lavrador MAS, Maffei CML, Candido RC. Evaluation of the Experimental Inoculation of Cryptococcus albidus and Cryptococcus laurentii in Normal Mice: Virulence Factors and Molecular Profile Before and After Animal Passage. Mycopathologia. 2009b; 168: 59–72. DOI 10.1007/s11046-009-9202-z
Rhodes JC, Roberts GD. Comparison of four methods for determining nitrate utilization by Cryptococci. Journal of Clinical Microbiology. 1975; 1: 9-10.
Rosario I, Acosta B, Colom F. La paloma yotrasavescomoreservorio de Cryptococcus spp. RevistaIberoamericana de Micología. 2008. doi:10.1016/s1130-1406(08)70020-2.
Shankar EM, Kumarasamy N, Bella D, Renuka S, Kownhar H, Suniti S, Rajan R, Rao UA. Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Canadian Respiratory Journal, 2006. https://doi.org/10.1155/ 2006/160451.
Sukroongreung S, Kitiniyom K, Nilakul C, Tantimava S. Pathogenicity of basidiospores of Filobasidiella neoformans var. neoformans. Medical Mycology, 1999; 36: 419 – 24.
Surawut S, Ondee T, Taratummarat S, Palaga T, Pisitkun P, Chindamporn A, Leelahavanichkul A. The role of macrophages in the susceptibility of Fc gamma receptor IIb deficient mice to Cryptococcus neoformans. Scientific Reports. 2017; 7: 40006.
Suvarna KS, Layton C, Bancroft JD. Bancroft’s Theory and Practice of Histological Techniques E-Book. Elsevier Health Science, 2012.
Thompson GR III, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill JR, Patterson TF. A murine model of Cryptococcus gattii meningoencephalitis. Journal of Antimicrobial Chemotherapy. 2012; 67: 1432-8

DOI
https://doi.org/10.62418/ijvph.9.2.2023.43-52
DOWNLOAD FULL ARTICAL
How to cite this article:
Corresponding author’s email ID: drnurul68@rediffmail.com
Citation: Islam N, Bharali R, Sarma HK, Talukdar S, Begum SA, Akand AH, Sarma S, Hussain SA. Experimental Pathogenicity of Papiliotrema laurentii in Swiss Albino Mice. Indian Journal of Veterinary Public Health. 2023; 9(2): 43-52.
DOI; https://doi.org/10.62418/ijvph.9.2.2023.43-52